Literature DB >> 2881057

Focus of Rift Valley fever virus transmission in southern Mauritania.

J F Saluzzo, J P Digoutte, C Chartier, D Martinez, R Bada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2881057     DOI： 10.1016/s0140-6736(87)92110-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

1.  Epidemiologic and clinical aspects of a Rift Valley fever outbreak in humans in Tanzania, 2007.

Authors:  Mohamed Mohamed; Fausta Mosha; Janeth Mghamba; Sherif R Zaki; Wun-Ju Shieh; Janusz Paweska; Sylvia Omulo; Solomon Gikundi; Peter Mmbuji; Peter Bloland; Nordin Zeidner; Raphael Kalinga; Robert F Breiman; M Kariuki Njenga
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

2.  Using a field quantitative real-time PCR test to rapidly identify highly viremic rift valley fever cases.

Authors:  M Kariuki Njenga; Janusz Paweska; Rose Wanjala; Carol Y Rao; Matthew Weiner; Victor Omballa; Elizabeth T Luman; David Mutonga; Shanaaz Sharif; Marcus Panning; Christian Drosten; Daniel R Feikin; Robert F Breiman
Journal:  J Clin Microbiol       Date:  2009-01-26       Impact factor: 5.948

3.  Comprehensive phylogenetic reconstructions of Rift Valley fever virus: the 2010 northern Mauritania outbreak in the Camelus dromedarius species.

Authors:  Ahmed B El Mamy; Modou M Lo; Yaya Thiongane; Mariame Diop; Katia Isselmou; Baba Doumbia; Mohammed Ould Baba; Ahmed S El Arbi; Renaud Lancelot; Y Kane; Emmanuel Albina; Catherine Cêtre-Sossah
Journal:  Vector Borne Zoonotic Dis       Date:  2014-12       Impact factor: 2.133

4.  Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife.

Authors:  A Evans; F Gakuya; J T Paweska; M Rostal; L Akoolo; P J Van Vuren; T Manyibe; J M Macharia; T G Ksiazek; D R Feikin; R F Breiman; M Kariuki Njenga
Journal:  Epidemiol Infect       Date:  2007-11-08       Impact factor: 2.451

5.  Serological and genomic evidence of Rift Valley fever virus during inter-epidemic periods in Mauritania.

Authors:  M Rissmann; M Eiden; B O El Mamy; K Isselmou; B Doumbia; U Ziegler; T Homeier-Bachmann; B Yahya; M H Groschup
Journal:  Epidemiol Infect       Date:  2016-12-28       Impact factor: 4.434

6.  Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.

Authors:  Céline Gommet; Agnès Billecocq; Grégory Jouvion; Milena Hasan; Tânia Zaverucha do Valle; Laurent Guillemot; Charlène Blanchet; Nico van Rooijen; Xavier Montagutelli; Michèle Bouloy; Jean-Jacques Panthier
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

7.  New vectors of Rift Valley fever in West Africa.

Authors:  D Fontenille; M Traore-Lamizana; M Diallo; J Thonnon; J P Digoutte; H G Zeller
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

8.  Combining hydrology and mosquito population models to identify the drivers of Rift Valley fever emergence in semi-arid regions of West Africa.

Authors:  Valérie Soti; Annelise Tran; Pascal Degenne; Véronique Chevalier; Danny Lo Seen; Yaya Thiongane; Mawlouth Diallo; Jean-François Guégan; Didier Fontenille
Journal:  PLoS Negl Trop Dis       Date:  2012-08-21

9.  A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.

Authors:  Elena López-Gil; Gema Lorenzo; Esther Hevia; Belén Borrego; Martin Eiden; Martin Groschup; Sarah C Gilbert; Alejandro Brun
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

10.  Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya.

Authors:  Peninah M Munyua; R Mbabu Murithi; Peter Ithondeka; Allen Hightower; Samuel M Thumbi; Samuel A Anyangu; Jusper Kiplimo; Bernard Bett; Anton Vrieling; Robert F Breiman; M Kariuki Njenga
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.